Epidemiology of ST131 in Besançon University Hospital

Centre Hospitalier Universitaire de Besancon300 enrolled

Overview

The sequence type 131 (ST131) is a predominant lineage among extraintestinal pathogenic Escherichia coli. It plays a major role in the worldwide dissemination of E. coli that produce extended-spectrum beta-lactamase (ESBL). The aim of this study was to describe the epidemiology of ESBL producing ST131clonal group in our university hospital. All patients with an infection due to ESBL E. coli will be prospectively included for a 2-year period. ST131 isolates will be identified and risk factors associated to ST131 will be determined in comparison to non-ST131 ESBL E. coli.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Escherichia Coli Infections

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Patients infected with ESBL producing E. coli Exclusion Criteria: * Patients known to be carrier or infected in the previous year, patients only colonised with ESBL producing E. coli.

Locations (1)

Centre Hospitalier Régional Universitaire

Besançon, France

Outcomes

Primary Outcomes

Risk factors associated to ESBL ST 131 infections

Time of hospitalization

Time frame: up to 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.